Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

About Warrior Met Coal Inc. Warrior Met Coal, Inc. engages in the production and export of metallurgical coal. It is focused on mining non-thermal steelmaking coal used as a component of steel ...

as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). Median overall survival, the primary outcome measure, was 23.7 months in those randomized to ...

In addition, those with known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC, were also not eligible for participation. The primary end point of the study was OS, and ...

Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC) and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We collected 486 faecal ...

In its first quarter 2025 investor letter, Black Bear Value Fund emphasized stocks such as Warrior Met Coal, Inc. (NYSE:HCC). Warrior Met Coal, Inc. (NYSE:HCC) produces and exports non-thermal ...

Chronic liver disease can be associated with liver cancer although some types, such as the rare fibrolamellar-hepatocellular carcinoma (FLL-HCC), occur in younger people with no history of a liver ...

aDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory ...

liver cancer multiomics analysis reveals that various disruptions in protein kinase A pathways collectively contribute to the development of fibrolamellar hepatocellular carcinoma. Key Market ...

Inspired by the anticancer properties of TH and the drug-enhancing potential of nanoscale GO, we modified rGO-TH nanosheets onto the surface of SV MBs, developing a novel nano-UCA (SV@rGO-TH MBs) for ...